Alexander H. Stegh

7.4k total citations · 3 hit papers
42 papers, 5.0k citations indexed

About

Alexander H. Stegh is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Alexander H. Stegh has authored 42 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Immunology. Recurrent topics in Alexander H. Stegh's work include RNA Interference and Gene Delivery (11 papers), Cell death mechanisms and regulation (9 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Alexander H. Stegh is often cited by papers focused on RNA Interference and Gene Delivery (11 papers), Cell death mechanisms and regulation (9 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Alexander H. Stegh collaborates with scholars based in United States, Japan and Israel. Alexander H. Stegh's co-authors include Ronald A. DePinho, Lynda Chin, Cameron Brennan, Jayne M. Stommel, Keith L. Ligon, David N. Louis, Robert Bachoo, Frank B. Furnari, Webster K. Cavenee and William C. Hahn and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Alexander H. Stegh

40 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Malignant astrocytic glioma: genetics, biology, and paths to treatment

2007 1.8k citations Frank B. Furnari, Tim R. Fenton et al. Genes & Development profile →
Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies

2007 699 citations Jayne M. Stommel, Alec C. Kimmelman et al. Science profile →
Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma

2013 493 citations Emily S. Day, Lisa Hurley et al. profile →

Peers

Alexander H. Stegh

GENET

ONCOL

IMMUN

William P. J. Leenders Netherlands

Nhan L. Tran United States

Carlotta A. Glackin United States

Hrvoje Miletić Norway

Frits Thorsen Norway

Sara Piccirillo Italy

Rodney B. Luwor Australia

Antoine E. Karnoub United States

Dinorah Friedmann‐Morvinski Israel

Shi‐Yuan Cheng United States

William P. J. Leenders Netherlands

Alexander H. Stegh

2.2k ×0.7

1.2k ×0.9

1.1k ×0.9

GENET

839 ×0.9

ONCOL

337 ×0.7

IMMUN

Citations per year, relative to Alexander H. Stegh Alexander H. Stegh (= 1×) peers William P. J. Leenders

Countries citing papers authored by Alexander H. Stegh

Since Specialization

Citations

This map shows the geographic impact of Alexander H. Stegh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander H. Stegh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander H. Stegh more than expected).

Fields of papers citing papers by Alexander H. Stegh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander H. Stegh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander H. Stegh. The network helps show where Alexander H. Stegh may publish in the future.

Co-authorship network of co-authors of Alexander H. Stegh

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander H. Stegh. A scholar is included among the top collaborators of Alexander H. Stegh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander H. Stegh. Alexander H. Stegh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Seung‐Hyun, Lisa Hurley, Serena Tommasini-Ghelfi, et al.. (2025). cGAS-agonistic spherical nucleic acids reprogram the glioblastoma immune microenvironment and promote antitumor immunity. Proceedings of the National Academy of Sciences. 122(45). e2409557122–e2409557122.

Kim, Seung‐Hyun, et al.. (2024). 1120 cGAS-agonistic and STAT3-inhibitory spherical nucleic acids generate durable anti-glioma response in a sex dependent manner. Regular and Young Investigator Award Abstracts. A1241–A1241. 1 indexed citations

Luo, Jingqin, Robyn S. Klein, Albert H. Kim, et al.. (2024). Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy. Proceedings of the National Academy of Sciences. 121(8). e2306973121–e2306973121. 12 indexed citations

Horbinski, Craig, et al.. (2023). Redox Homeostasis and Beyond: The Role of Wild-Type Isocitrate Dehydrogenases for the Pathogenesis of Glioblastoma. Antioxidants and Redox Signaling. 39(13-15). 923–941. 4 indexed citations

May, Jasmine, Fotini M. Kouri, Lisa Hurley, et al.. (2019). IDH3α regulates one-carbon metabolism in glioblastoma. Science Advances. 5(1). eaat0456–eaat0456. 55 indexed citations

Tommasini-Ghelfi, Serena, et al.. (2019). Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydrogenases in human disease. Science Advances. 5(5). eaaw4543–eaaw4543. 108 indexed citations

Hashizume, Rintaro, Ali Zhang, Sabine Mueller, et al.. (2016). Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth. Neuro-Oncology. 18(11). now106–now106. 100 indexed citations

Kouri, Fotini M., Carissa Ritner, & Alexander H. Stegh. (2015). miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics. Cell Cycle. 14(24). 3794–3800. 41 indexed citations

Rouge, Jessica L., Timothy L. Sita, Liang Hao, et al.. (2015). Ribozyme–Spherical Nucleic Acids. Journal of the American Chemical Society. 137(33). 10528–10531. 54 indexed citations

10.

Barnaby, Stacey N., Timothy L. Sita, Sarah Hurst Petrosko, Alexander H. Stegh, & Chad A. Mirkin. (2015). Therapeutic Applications of Spherical Nucleic Acids. Cancer treatment and research. 166. 23–50. 36 indexed citations

11.

Kouri, Fotini M., Lisa Hurley, Weston L. Daniel, et al.. (2015). miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes & Development. 29(7). 732–745. 179 indexed citations

12.

Yoshida, Yasuyuki, Tomoko Ozawa, Shen Wang, et al.. (2014). NT113, a Pan-ERBB Inhibitor with High Brain Penetrance, Inhibits the Growth of Glioblastoma Xenografts with EGFR Amplification. Molecular Cancer Therapeutics. 13(12). 2919–2929. 15 indexed citations

13.

Queisser, Markus A., Laura A. Dada, Martín Angulo, et al.. (2014). HOIL-1L Functions as the PKCζ Ubiquitin Ligase to Promote Lung Tumor Growth. American Journal of Respiratory and Critical Care Medicine. 190(6). 688–698. 32 indexed citations

14.

Stegh, Alexander H.. (2012). Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils. Expert Opinion on Therapeutic Targets. 16(1). 67–83. 160 indexed citations

15.

Stegh, Alexander H. & Ronald A. DePinho. (2011). Beyond effector caspase inhibition. Cell Cycle. 10(1). 33–38. 58 indexed citations

16.

Stegh, Alexander H., Lynda Chin, David N. Louis, & Ronald A. DePinho. (2008). What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator. Cell Cycle. 7(18). 2833–2839. 43 indexed citations

17.

Stommel, Jayne M., Alec C. Kimmelman, Haoqiang Ying, et al.. (2007). Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies. Science. 318(5848). 287–290. 699 indexed citations breakdown →

18.

Furnari, Frank B., Tim R. Fenton, Robert Bachoo, et al.. (2007). Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes & Development. 21(21). 2683–2710. 1804 indexed citations breakdown →

19.

Stegh, Alexander H., Bryan C. Barnhart, Jörg Volkland, et al.. (2002). Inactivation of Caspase-8 on Mitochondria of Bcl-xL-expressing MCF7-Fas Cells. Journal of Biological Chemistry. 277(6). 4351–4360. 96 indexed citations

20.

Stegh, Alexander H. & Marcus E. Peter. (2001). APOPTOSIS AND CASPASES. Cardiology Clinics. 19(1). 13–29. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact